Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Dier Mardi
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   101,126    

Indirect Shares

   875      
Direct Value   $4,730,138    

Indirect Value

   $4,148      
Total Shares   102,001      
Total Value   $4,734,285      


Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,742,498 Acelyrin, Inc. $26,335 Madrigal Pharmaceuticals Inc $1,879,104 Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,742,498 Acelyrin, Inc. $26,335 Madrigal Pharmaceuticals Inc $1,879,104
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   -2.0   
   1.0   
     Percentage Gain/Loss :
   -71.0%
 18.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Portola Pharmaceuticals Inc PTLA EVP and CFO 2020-07-02 0 0    Premium*  
            Adamas Pharmaceuticals Inc ADMS Director 2021-06-02 10,000 2020-06-03 0    Premium*  
            Prelude Therapeutics Inc PRLD Director 2020-09-29 10,000 2020-09-29 0    Premium*  
            Ultragenyx Pharmaceutical Inc RARE CFO & Executive Vice P... 2022-10-14 66,695 2020-10-12 0    Premium*  
            Acelyrin, Inc. SLRN CFO and CBO 2023-05-09 5,556 2023-05-09 875    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-03-11 8,875 0    Premium*  
* Premium Members only  

Records found :    73         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-01-27 4 A $0.00 $0 D/D 12,000 12,000 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2016-01-27 4 A $0.00 $0 D/D 13,750 13,750 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2016-05-01 4 A $0.00 $0 D/D 16,250 16,250 0 -
PTLA Portola Pharmaceuticals I... EVP and CFO   •       –      –    2017-01-30 4 A $0.00 $0 D/D 15,625 15,625 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-01-31 4 A $0.00 $0 D/D 10,625 10,625 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-05-22 4 A $0.00 $0 D/D 5,859 118,785 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-01-12 4 A $0.00 $0 D/D 2,125 98,800 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-01-31 4 A $0.00 $0 D/D 18,750 116,682 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-05-19 4 A $0.00 $0 D/D 5,859 72,592 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-01-12 4 A $0.00 $0 D/D 2,125 69,995 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-01-31 4 A $0.00 $0 D/D 16,250 84,968 0 -
ADMS Adamas Pharmaceuticals In... Director   –       •      –    2020-06-03 4 A $0.00 $0 D/D 5,000 5,000 0 -
PTLA Portola Pharmaceuticals I... EVP and CFO   •       –      –    2020-06-18 4 A $8.36 $84 D/D 10 10 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-10-12 4 A $0.00 $0 D/D 40,000 40,000 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2021-03-01 4 A $0.00 $0 D/D 5,500 45,500 0 -
ADMS Adamas Pharmaceuticals In... Director   –       •      –    2021-06-02 4 A $0.00 $0 D/D 5,000 10,000 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2022-03-01 4 A $0.00 $0 D/D 14,000 52,228 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2022-09-16 4 A $0.00 $0 D/D 20,000 71,808 0 -
PTLA Portola Pharmaceuticals I... Senior VP and CFO   •       –      –    2014-03-25 4 AS $25.69 $128,433 D/D (5,000) 29,824 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-04-25 4 AS $24.13 $120,725 D/D (5,000) 24,824 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-05-29 4 AS $23.00 $115,000 D/D (5,000) 19,824 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-06-18 4 AS $29.95 $110,995 D/D (3,706) 16,118 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-06-25 4 AS $28.52 $142,600 D/D (5,000) 11,118 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-07-25 4 AS $24.11 $120,568 D/D (5,000) 6,118 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-08-25 4 AS $25.72 $131,314 D/D (5,000) 1,118 0 -
  73  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us